Optineurin downregulation induces endoplasmic reticulum stress, chaperone-mediated autophagy, and apoptosis in pancreatic cancer cells
暂无分享,去创建一个
[1] M. Berger,et al. Multiple Facets of Autophagy and the Emerging Role of Alkylphosphocholines as Autophagy Modulators , 2020, Frontiers in Pharmacology.
[2] K. N. Diakopoulos,et al. The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside , 2020, Cells.
[3] S. Tooze,et al. The Role of Autophagy in Pancreatic Cancer—Recent Advances , 2019, Biology.
[4] Wenming Li,et al. Signaling and induction of chaperone-mediated autophagy by the endoplasmic reticulum under stress conditions , 2018, Autophagy.
[5] Shuling Song,et al. Crosstalk of ER stress‐mediated autophagy and ER‐phagy: Involvement of UPR and the core autophagy machinery , 2018, Journal of cellular physiology.
[6] R. König,et al. Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells , 2018, Cell Death & Disease.
[7] Michael Lee,et al. Knockout of ATG5 leads to malignant cell transformation and resistance to Src family kinase inhibitor PP2 , 2018, Journal of cellular physiology.
[8] R. Jeffrey,et al. Extrapancreatic perineural invasion in pancreatic adenocarcinoma , 2018, Abdominal Radiology.
[9] M. Reni,et al. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. , 2017, Cancer treatment reviews.
[10] C. Lindskog,et al. A pathology atlas of the human cancer transcriptome , 2017, Science.
[11] M. Falasca,et al. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies , 2017, International journal of molecular sciences.
[12] Yan Jiang,et al. CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[13] A. Rucki,et al. Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma. , 2017, Journal of gastrointestinal oncology.
[14] Devin P. Sullivan,et al. A subcellular map of the human proteome , 2017, Science.
[15] T. Luedde,et al. Current and future biomarkers for pancreatic adenocarcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[16] M. Berger,et al. Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action - a short report , 2017, Cellular Oncology.
[17] Jianping Liu,et al. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins , 2016, Nature Communications.
[18] O. Nureki,et al. Crystal structure of Optineurin UBAN in complex with linear ubiquitin , 2016 .
[19] M. Vooijs,et al. LC3/GABARAP family proteins: autophagy‐(un)related functions , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] O. Nureki,et al. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis , 2016, Nature Communications.
[21] R. Qin,et al. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells , 2016, Autophagy.
[22] B. Yue,et al. Optineurin: The autophagy connection. , 2016, Experimental eye research.
[23] E. Giovannetti,et al. Unraveling the complexity of autophagy: Potential therapeutic applications in Pancreatic Ductal Adenocarcinoma. , 2015, Seminars in cancer biology.
[24] P. Cohen,et al. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget’s Disease , 2015, Cell reports.
[25] K. Koike,et al. Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress , 2015, BMC Cancer.
[26] C. Guillemette,et al. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism , 2015, Oncotarget.
[27] S. Bloom,et al. Optineurin deficiency in mice contributes to impaired cytokine secretion and neutrophil recruitment in bacteria-driven colitis , 2015, Disease Models & Mechanisms.
[28] Caimin Xu,et al. The switch from ER stress-induced apoptosis to autophagy via ROS-mediated JNK/p62 signals: A survival mechanism in methotrexate-resistant choriocarcinoma cells. , 2015, Experimental cell research.
[29] M. Hidalgo,et al. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies , 2015, Nature Reviews Clinical Oncology.
[30] L. Pfeffer,et al. Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells , 2015, Viruses.
[31] Guang-Chao Chen,et al. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism , 2015, Autophagy.
[32] Shumei Ma,et al. Hsp90 regulates autophagy and plays a role in cancer therapy , 2015, Tumor Biology.
[33] Yan Zhao,et al. Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer. , 2014, Oncology reports.
[34] E. Holzbaur,et al. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation , 2014, Proceedings of the National Academy of Sciences.
[35] H. Ji,et al. Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. , 2014, Cancer cell.
[36] S. Minoshima,et al. Oligomerization of Optineurin and Its Oxidative Stress- or E50K Mutation-Driven Covalent Cross-Linking: Possible Relationship with Glaucoma Pathology , 2014, PloS one.
[37] A. Thorburn,et al. Regulation of cell proliferation and migration by p62 through stabilization of Twist1 , 2014, Proceedings of the National Academy of Sciences.
[38] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[39] M. Hirota,et al. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs. , 2014, European journal of cancer.
[40] Yidong Chen,et al. PELP1 oncogenic functions involve alternative splicing via PRMT6 , 2014, Molecular oncology.
[41] B. Yue,et al. Effects of mutations and deletions in the human optineurin gene , 2014, SpringerPlus.
[42] A. Cuervo,et al. Chaperone-mediated autophagy: roles in disease and aging , 2013, Cell Research.
[43] D. Seo,et al. PRMT6 overexpression upregulates TSP-1 and downregulates MMPs: its implication in motility and invasion. , 2013, Biochemical and biophysical research communications.
[44] M. Pawlita,et al. High‐throughput SNP‐based authentication of human cell lines , 2013, International journal of cancer.
[45] Lei Wang,et al. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma , 2013, Molecular Cancer.
[46] U. Bauer,et al. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes , 2012, Nucleic acids research.
[47] E. Laplantine,et al. Toward an integrative view of Optineurin functions , 2012, Cell cycle.
[48] Satya N. Das,et al. Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma. , 2012, Cancer letters.
[49] E. Laplantine,et al. Optineurin: a new vision of cell division control. , 2012, Cell cycle.
[50] T. Tan,et al. Protein arginine methyltransferase 6 regulates embryonic stem cell identity. , 2012, Stem cells and development.
[51] A. Bauch,et al. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. , 2012, Molecular cell.
[52] B. Yue,et al. Cellular and molecular biology of optineurin. , 2012, International review of cell and molecular biology.
[53] K. Okamoto,et al. Optineurin in neurodegenerative diseases , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[54] Bo Liu,et al. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. , 2011, Biochemical and biophysical research communications.
[55] P. Cohen,et al. Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon β* , 2011, The Journal of Biological Chemistry.
[56] Sebastian A. Wagner,et al. Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth , 2011, Science.
[57] Marc Liesa,et al. Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.
[58] J. Sellers,et al. Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane , 2011, Molecular biology of the cell.
[59] Y. Qiu,et al. Processing of Optineurin in Neuronal Cells* , 2010, The Journal of Biological Chemistry.
[60] A. Harris,et al. Regulation of autophagy by ATF4 in response to severe hypoxia , 2010, Oncogene.
[61] V. Radha,et al. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant , 2010, BMC Cell Biology.
[62] A. Harris,et al. Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia , 2009, Cell cycle.
[63] G. Swarup,et al. Optineurin and Its Mutants: Molecules Associated with Some Forms of Glaucoma , 2009, Ophthalmic Research.
[64] G. Egea,et al. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. , 2009, Molecular biology of the cell.
[65] D. Klionsky,et al. Autophagy and Human Disease , 2007, Cell cycle.
[66] G. Diez-Roux,et al. Optineurin Increases Cell Survival and Translocates to the Nucleus in a Rab8-dependent Manner upon an Apoptotic Stimulus* , 2006, Journal of Biological Chemistry.
[67] G. Spudich,et al. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis , 2005, The Journal of cell biology.
[68] A. Meijer,et al. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. , 1997, European journal of biochemistry.
[69] K Y Hui,et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.